These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7316489)

  • 1. Clinical and biochemical heterogeneity of globoid cell leukodystrophy.
    Farrell DF; Swedberg K
    Ann Neurol; 1981 Oct; 10(4):364-8. PubMed ID: 7316489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset globoid cell leucodystrophy (Krabbe's disease). Clinical and genetic delineation of two forms and their relation to the early-infantile form.
    Loonen MC; Van Diggelen OP; Janse HC; Kleijer WJ; Arts WF
    Neuropediatrics; 1985 Aug; 16(3):137-42. PubMed ID: 4047347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolysis of galactosylceramide is catalyzed by two genetically distinct acid beta-galactosidases.
    Kobayashi T; Shinnoh N; Goto I; Kuroiwa Y
    J Biol Chem; 1985 Dec; 260(28):14982-7. PubMed ID: 3934152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoelectric focusing of galactosylceramide beta-galactosylceramide beta-galactosidase in cultured skin fibroblasts of patients with Krabbe's globoid-cell leucodystrophy.
    Besley GT
    Biochem Soc Trans; 1975; 3(2):241-4. PubMed ID: 1132549
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular basis of late-life globoid cell leukodystrophy.
    De Gasperi R; Gama Sosa MA; Sartorato E; Battistini S; Raghavan S; Kolodny EH
    Hum Mutat; 1999; 14(3):256-62. PubMed ID: 10477434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
    Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
    Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
    Shin D; Feltri ML; Wrabetz L
    J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical diagnosis of globoid cell leukodystrophy (Krabbe's disease)].
    Tsvetkova IV; Zolotukhina TV; Rozenfel'd RA
    Vopr Med Khim; 1985; 31(2):128-30. PubMed ID: 2860752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of galactosylceramidase activation by phosphatidylserine.
    Hanada E; Suzuki K
    Biochim Biophys Acta; 1980 Aug; 619(2):396-402. PubMed ID: 6773584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
    Suzuki K
    Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipid beta-D-galactosidases in globoid cell leukodystrophy (Krabbe disease).
    Awasthi YC; Lund HW; Lo JT; Srivastava SK
    Birth Defects Orig Artic Ser; 1978; 14(6B):113-26. PubMed ID: 103589
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of galactosylceramide in the twitcher mouse, an animal model of human globoid cell leukodystrophy.
    Kobayashi T; Shinnoh N; Kuroiwa Y
    Biochim Biophys Acta; 1986 Nov; 879(2):215-20. PubMed ID: 3094585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications.
    Wenger DA; Rafi MA; Luzi P
    Hum Mutat; 1997; 10(4):268-79. PubMed ID: 9338580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
    Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
    Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of psychosine upon growth of human skin fibroblasts from patients with globoid cell leukodystrophy.
    Dickerman LH; Kurczynski TW; Macbride RG
    J Neurol Sci; 1981 May; 50(2):181-90. PubMed ID: 7229663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine.
    Kobayashi T; Goto I; Yamanaka T; Suzuki Y; Nakano T; Suzuki K
    Ann Neurol; 1988 Oct; 24(4):517-22. PubMed ID: 3239954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krabbe's globoid cell leucodystrophy. Studies on galactosylceramide beta-galactosidase and non-specific beta-galactosidase of leucocytes, cultured skin fibroblasts, and amniotic fluid cells.
    Besley GT; Bain AD
    J Med Genet; 1976 Jun; 13(3):195-9. PubMed ID: 819652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Globoid cell leukodystrophy (Krabbe's disease). Metabolic studies with cultured fibroblasts.
    Tanaka H; Suzuki K
    J Neurol Sci; 1978 Oct; 38(3):409-19. PubMed ID: 731265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late onset Krabbe disease due to the new GALC p.Ala543Pro mutation, with intriguingly high residual GALC activity in vitro.
    Krägeloh-Mann I; Harzer K; Rostásy K; Beck-Wödl S; Bornemann A; Böhringer J; Bevot A; Beck V; Merkel G; Pechan M
    Eur J Paediatr Neurol; 2017 May; 21(3):522-529. PubMed ID: 28109651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
    Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
    Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.